Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | EMBO Molecular Medicine | journal | 5.419 Q1 | 142 | 78 | 103 | 3014 | 777 | 88 | 7.54 | 38.64 | 39.40 | |
2 | Molecular Oncology | journal | 2.489 Q1 | 113 | 55 | 143 | 3267 | 587 | 116 | 4.61 | 59.40 | 39.57 | |
3 | Molecular Cancer | journal | 2.303 Q1 | 196 | 151 | 542 | 8091 | 2589 | 538 | 4.66 | 53.58 | 38.74 | |
4 | Journal of Cellular and Molecular Medicine | journal | 1.981 Q1 | 157 | 244 | 900 | 13379 | 4056 | 870 | 4.33 | 54.83 | 42.87 | |
5 | BMC Chemical Biology | journal | 1.979 Q1 | 21 | 2 | 17 | 74 | 73 | 17 | 4.07 | 37.00 | 30.77 | |
6 | Molecular Pain | journal | 1.855 Q1 | 96 | 102 | 240 | 5213 | 1076 | 238 | 3.99 | 51.11 | 38.96 | |
7 | Genome Medicine | journal | 1.668 Q1 | 123 | 75 | 206 | 3370 | 770 | 140 | 3.74 | 44.93 | 39.92 | |
8 | Cellular Oncology | journal | 1.405 Q2 | 44 | 0 | 106 | 0 | 280 | 83 | 2.99 | 0.00 | 0.00 | |
9 | Expert Review of Vaccines | journal | 1.405 Q2 | 105 | 167 | 435 | 11738 | 1689 | 350 | 3.91 | 70.29 | 30.99 | |
10 | Journal of Nanobiotechnology | journal | 1.142 Q2 | 109 | 57 | 58 | 2106 | 277 | 58 | 4.11 | 36.95 | 34.94 | |
11 | Human Genomics | journal | 1.126 Q2 | 68 | 36 | 89 | 1912 | 262 | 75 | 3.08 | 53.11 | 41.72 | |
12 | AIDS Research and Therapy | journal | 0.983 Q2 | 49 | 43 | 103 | 1338 | 258 | 103 | 2.26 | 31.12 | 44.27 | |
13 | Molecular Cytogenetics | journal | 0.962 Q2 | 38 | 27 | 51 | 939 | 123 | 50 | 2.37 | 34.78 | 56.89 | |
14 | Stem Cell Research and Therapy | journal | 0.846 Q3 | 122 | 50 | 41 | 2452 | 134 | 40 | 3.27 | 49.04 | 38.12 | |
15 | Molecules | journal | 0.720 Q3 | 227 | 757 | 1294 | 30780 | 3570 | 1290 | 2.70 | 40.66 | 38.85 | |
16 | Clinical Proteomics | journal | 0.609 Q3 | 42 | 17 | 47 | 589 | 74 | 43 | 1.34 | 34.65 | 29.89 | |
17 | Pharmaceuticals | journal | 0.431 Q3 | 87 | 89 | 208 | 7520 | 256 | 204 | 1.23 | 84.49 | 32.59 | |
18 | Pharmaceutical Biology | journal | 0.364 Q4 | 88 | 178 | 537 | 6266 | 648 | 531 | 1.10 | 35.20 | 39.60 | |
19 | EXCLI Journal | journal | 0.165 Q4 | 55 | 44 | 48 | 1448 | 56 | 47 | 1.17 | 32.91 | 39.78 | |
20 | Frontiers in Genetics | journal | 0.147 Q4 | 120 | 94 | 2 | 4222 | 2 | 2 | 1.00 | 44.91 | 35.46 | |
21 | Pteridines | journal | 0.113 Q4 | 19 | 12 | 35 | 444 | 9 | 34 | 0.23 | 37.00 | 43.75 | |
22 | Drugs in Context | journal | 0.101 Q4 | 36 | 0 | 20 | 0 | 0 | 18 | 0.00 | 0.00 | 0.00 | |
23 | Cellular oncology (Dordrecht) | journal | 58 | 52 | 0 | 2170 | 0 | 0 | 0.00 | 41.73 | 42.45 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®